Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)
Clinical trial NCT03370913 · COMPLETED
Trial details
- NCT number
- NCT03370913
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2020-11-16
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.